The GDCh Division of Medicinal Chemistry together with the Pharmaceutical / medicinal chemistry Division of the German Pharmaceutical Society (DPhG) awards the Innovation Award for Medicinal and Pharmaceutical Chemistry. The award recognizes outstanding scientific publications and results in the fields of medicinal and pharmaceutical chemistry. Associated with the award are an award certificate and prize money of 5000 euros donated by the two Divisions . The award usually takes place annually as part of the "Frontiers in Medicinal Chemistry" Conference . The prize can be shared.
The Innovation Award 2021 was awarded to Prof. Dr. Pierre Koch and Ass.-Prof. Dr. Nina Schützenmeister on the occasion of the Online Conference "Frontiers in Medicinal Chemistry 2021".
The award is given to Prof. Dr. Koch awarded in recognition of his outstanding, original and forward-looking research work. Dr. Koch developed selective kinase inhibitors that are able to penetrate the central nervous system. These kinase inhibitors represent an innovative approach to the therapy of neurodegenerative diseases such as Alzheimer's dementia and multiple sclerosis. The scientific success of this innovative research is documented by numerous publications in respected journals.
The award is given to Prof. Dr. Schützenmeister awarded in recognition of their outstanding, original and forward-looking research work. Dr. Schützenmeister carried out innovative work on the synthesis of biologically active natural substances. She developed new and efficient synthesis methods and used them to obtain antibacterial and antiviral natural substances and natural substance analogues. In this way, novel analogues for improving biological activity become accessible. The scientific success of this innovative and highly independent research work is documented by publications in respected journals.
The Innovation Award award 2020 was given to PD Dr. Oliver Koch and PD Dr. Daniel Merk forgive.
PD Dr. Oliver Koch in recognition of his outstanding, original and forward-looking research. Dr. Koch carried out pioneering work on the development and application of computational methods for the rational molecular design of new biologically active substances. In particular, he dealt with targets for combating mycobacterial infections and for modulating epigenetic processes. The scientific success of this innovative and extremely independent research work is documented in numerous publications in respected journals.
PD Dr. Daniel Merk in recognition of his excellent, original and forward-looking research. Dr. Merk did innovative work on the modulation of nuclear receptors. This important class of proteins offers little-known potential new targets for drug development. Dr. Merk used a wide range of methods for his previous research work, which also includes computer-aided methods. In his still young academic career, he has already achieved an astonishing number of high-quality publications.
The Innovation Award award 2019 was given to Dr. Andreas Brunschweiger in recognition of his outstanding, original and pioneering research work on the occasion of the annual conference "Frontiers in Medicinal Chemistry", which developed and synthesized innovative DNA-encoded substance libraries for numerous substance classes. These libraries enable fast and efficient identification of new lead structures in drug research.
|2020|| PD Dr. Oliver Koch, Münster|
PD Dr. Daniel Merk, Frankfurt
|2019||Dr. Andreas Brunschweiger, Dortmund|
Prof. Dr. Finn K. Hansen, Leipzig
|2017||Prof. Dr. Anna Katharina Herta Hirsch, Saarbrücken|
Dr. Andreas Koeberle, Jena
|2015|| Dr. Nuska Tschammer, Erlangen
Dr. Peter Kolb, Marburg
|2014||Jun.-Prof. Dr. Peter Wich, Mainz|
|2013||Dr. Johanne Notni, Munich|
|2012||Dr. Christian Ottman, Dortmund|
|2011|| Jun.-Prof. Dr. Ingo Ott, Braunschweig
Dr. Andreas Bender, Cambridge, UK
|2010||Dr. Daniel Rauh, Dortmund|
|2008||Dr. Franz von Nussbaum, Wuppertal|
|2007||Prof. Dr. Christoph Sotriffer, Marburg|
|2006||PD Dr. Andrea Sinz, Leipzig|
|2005|| PD Dr. Eric Beitz, Tübingen
Dr. Holger Gohlke, Frankfurt
|2003||PD Dr. Franz F. Paintner, Munich|
|2002||Dr. Jörg Rademann, Tübingen|
|2001|| Dr. Andreas Link, Hamburg
Dr. Wolfgang Sippl, Düsseldorf
|2000||Dr. Manfred Jung, Münster|
|1999|| PD Dr. Thomas Carell, Zurich, Switzerland
Dr. Martin Schlitzer, Marburg
|1998|| Habilitation award|
Dr. Joachim Jose
Dr. Tanja Schirmeister
last modified: 27.04.2021 10:55 H from rkl